Beauty Farm Medical and Health Industry Inc. disclosed a share repurchase on 28 April 2026, buying back 50,000 ordinary shares on the Hong Kong Stock Exchange.

The shares were repurchased at prices between HKD 20.66 and HKD 21.10, for a volume-weighted average of HKD 20.91 per share. Aggregate consideration amounted to HKD 1.05 million.

After the transaction, issued shares excluding treasury stock decreased to 249.90 million, while treasury shares increased to 1.69 million. Total shares outstanding (including treasury shares) remained unchanged at 251.59 million. The buyback represented approximately 0.02% of the company’s issued share capital (excluding treasury shares) prior to the transaction.

Under the repurchase mandate approved on 27 June 2025, Beauty Farm is authorised to buy back up to 23.58 million shares. Cumulative repurchases under this mandate have reached 1.69 million shares, equivalent to 0.72% of the shares in issue when the resolution was passed.

In line with Hong Kong listing rules, the company is subject to a moratorium on issuing new shares or transferring treasury shares until 28 May 2026.